Evidence map›Paper›PMID 26445504›Full record

ArticlePloS one2015

Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency.

Lin Li, Ryan M Walsh, Vilas Wagh, Marianne F James, Roberta L Beauchamp, Yuh-Shin Chang, James F Gusella, Konrad Hochedlinger, Vijaya Ramesh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. NF2 is Essential for Human Endoderm Development.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
  5. Article
  6. Genetically Engineered Mice Unveil In Vivo Roles of the Mediator Complex.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lin LiCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Ryan M WalshCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Vilas WaghCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Marianne F JamesCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Roberta L BeauchampCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Yuh-Shin ChangCardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
James F GusellaCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Harvard Stem Cell Institute, Cambridge, Massachusetts, United States of America.
Konrad HochedlingerCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Harvard Stem Cell Institute, Cambridge, Massachusetts, United States of America.
Vijaya RameshCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Massachusetts General Hospital · USCenter for Human Genetics · USHarvard Stem Cell Institute · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI A. Heather Eliassen · 1985 to 2026
$330.6M
SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
Preclinical Treatment for NF2-Associated TumorsR21NS082482 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI JAMES, MARIANNE, RAMESH, VIJAYA · 2013 to 2014
$476k
NCI NIH HHS 5 P30 CA06516NCI NIH HHS P30 CA006516NICHD NIH HHS P30 HD018655NINDS NIH HHS NS082482NINDS NIH HHS R21 NS082482
6 · The paper itself

Abstract

The multi-subunit mammalian Mediator complex acts as an integrator of transcriptional regulation by RNA Polymerase II, and has emerged as a master coordinator of development and cell fate determination. We previously identified the Mediator subunit, MED28, as a cytosolic binding partner of merlin, the Neurofibromatosis 2 (NF2) tumor suppressor, and thus MED28 is distinct in having a cytosolic role as an NF2 interacting protein as well as a nuclear role as a Mediator complex subunit. Although limited in vitro studies have been performed on MED28, its in vivo function remains unknown. Employing a knockout mouse model, we describe for the first time the requirement for Med28 in the developing mouse embryo. Med28-deficiency causes peri-implantation lethality resulting from the loss of pluripotency of the inner cell mass accompanied by reduced expression of key pluripotency transcription factors Oct4 and Nanog. Further, overexpression of Med28 in mouse embryonic fibroblasts enhances the efficiency of their reprogramming to pluripotency. Cre-mediated inactivation of Med28 in induced pluripotent stem cells shows that Med28 is required for their survival. Intriguingly, heterozygous loss of Med28 results in differentiation of induced pluripotent stem cells into extraembryonic trophectoderm and primitive endoderm lineages. Our findings document the essential role of Med28 in the developing embryo as well as in acquisition and maintenance of pluripotency during reprogramming.

Indexed as

Embryo ImplantationGene Expression Regulation, DevelopmentalAnimalsCell DifferentiationCellular ReprogrammingEmbryo LossGene DeletionInduced Pluripotent Stem CellsMediator ComplexMiceMice, Inbred C57BLMice, KnockoutMed28 protein, mouseMediator Complex

Identifiers

PMID26445504
PMCPMC4596692
OpenAlexW2197121310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.